Lansdowne Partners
https://www.lansdownepartners.com/Lansdowne Partners, a global alternative investment firm, invests in the public equity and alternative markets of the United States and United Kingdom. Lansdowne Partners was founded in 1998.
View Older Stories View More Recent Stories
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Jun 30
-
Exclusive: Woodford biotech stakes first off block in asset sale - source
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Mar 31
-
Inmarsat convinced by $3.4 billion cash buyout deal
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Dec 31
-
Form SC 13G/A Manchester United plc Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Form SC 13D/A Summit Therapeutics plc Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Holding(s) in Company
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Sep 30
-
Holding(s) in Company
-
Form SC 13G/A Manchester United plc Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Tencent-backed Meituan raises $4.2 billion in IPO priced near range top-sources
-
China's Meituan Dianping sets HK IPO valuation at up to $55 billion: sources
-
Lansdowne Partners Announces Decrease in its Holding in Junex
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Jun 30
-
Junex Receives Unsolicited Offer
-
Junex Receives Unsolicited Offer
-
Junex Inc. Receives Unsolicited Offer
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Mar 31
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Dec 31
-
Hedge funds bet against some Italian banks on the rise
-
Form SC 13G/A CYTOKINETICS INC Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Form SC 13D/A Summit Therapeutics plc Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Exscientia Appoints Alex Snow, Founder of Oxford Innovation Sciences and Former CEO of Lansdowne Partners, as Deputy Chairman
-
Hedge fund bet on Glencore backfires with $100 million loss
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Sep 30
-
Junex Closes a $3.9 Million Private Placement
-
Form SC 13D/A Summit Therapeutics plc Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Jun 30
-
Evotec AG: LAB282 Accelerates with Second Round Funding
-
Equity Strategies Snag All Top 20 Spots on eVestment Global Screening List; UK Users Globally Focused
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Mar 31
-
Banks come in from the cold for hedge funds
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Dec 31
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Sep 30
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Jun 30
-
Form SC 13D/A Alexza Pharmaceuticals Filed by: LANSDOWNE PARTNERS AUSTRIA GMBH
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Mar 31
-
Form 13F-HR LANSDOWNE PARTNERS AUSTR For: Dec 31
-
Form SC 13G/A RESPONSE GENETICS INC Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Form SC 13G/A CYTOKINETICS INC Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Dec 31
-
Form SC 13G/A Manchester United plc Filed by: LANSDOWNE PARTNERS (UK) LLP
-
Form 13F-HR LANSDOWNE PARTNERS AUSTR For: Sep 30
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Sep 30
-
From gold to hard-hit Brazilian real, hedge funds place their bets
-
Form 13F-HR LANSDOWNE PARTNERS AUSTR For: Jun 30
-
Form 13F-HR LANSDOWNE PARTNERS (UK) For: Jun 30
-
Form SC 13D Alexza Pharmaceuticals Filed by: LANSDOWNE PARTNERS AUSTRIA GMBH
-
Former Elan CEO Takes Helm of Expanded Serenus Biotherapeutics Board of Directors

